Global Gamma Knife Market Analysis Report : Asia to Witness Highest Growth by 2027

Gamma Knife radiosurgery is a type of radiation therapy that is commonly used to treat brain metastases. The global brain metastases market grew at a CAGR of 3.7 percent from USD 360,610.2 thousand in 2014 to USD 448,903.1 thousand in 2020, owing to a significant increase in the global Gamma Knife market from USD 526,733.2 thousand in 2014 to USD 651,241.9 thousand by 2027, growing at a CAGR of 3.6 percent.

Radiation therapy is a treatment that involves precisely administering high doses of radiation to cancers and other anatomical targets. Brain tumours, arteriovenous malformations, trigeminal neuralgia, acoustic neuroma, and pituitary tumours are the most common conditions treated with it. Specialized equipment concentrates close to 200 small beams of radiation on a tumour or other targeted cells in Gamma Knife surgery. These beams deliver high doses of radiation to tumour cells with pinpoint accuracy. This practically means that healthy tissues in the immediate vicinity are exposed to very little or no radiation.

The Gamma Knife business is booming around the world, thanks to rising cancer and obesity rates, as well as an ageing population. Furthermore, the growing number of efforts made by various government organisations, as well as the enhanced features of Gamma Knife systems, are propelling the market forward.

For the forecast period of 2021-2028, the global gamma knife market is on the rise and will continue to do so. The gamma knife market, which is currently valued at USD 269.53 million, will grow to USD 342.23 million by the end of the projected period. This is due to an increasing global understanding of the benefits of this radiation therapy. Following current trends, the worldwide gamma knife market is expected to grow at a 3.03 percent CAGR.